Hyper-mutational processes provide a head-start for weak cancer drivers: Explaining atypical KRAS variants.

Hypermutational processes can explain the dominance of weak, atypical KRAS driver mutations in POLE-mutant colorectal cancers, with mutation bias and rate playing key roles.

• Why it matters: Understanding why weak cancer drivers persist over stronger ones is crucial for insights into tumor evolution and potential therapeutic targets, especially in hypermutant cancers.
• What they did: Using mathematical modeling, the study examined how increased mutation rates and biases toward specific nucleotide contexts influence driver mutation prevalence, focusing on POLE-mutant and mismatch repair-deficient colorectal cancers.
• The result: The findings suggest that elevated mutation rates combined with mutational biases are sufficient to explain the enrichment of atypical KRAS drivers, reducing the need to invoke differential selection in tumor evolution.